You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,925,829


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,925,829 protect, and when does it expire?

Patent 10,925,829 protects TASCENSO ODT and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 10,925,829
Title:Stable solid fingolimod dosage forms
Abstract: The present invention relates to a solid pharmaceutical dosage forms and methods for preparing the solid pharmaceutical dosage form that contains fingolimod or its pharmaceutically acceptable salts, conjugates or complexes thereof. The solid pharmaceutical dosage forms may rapidly disintegrate in a patient's oral cavity.
Inventor(s): Liu; Fangyu (Saratoga, CA)
Assignee: Handa Neuroscience, LLC (San Jose, CA)
Application Number:16/778,186
Patent Claim Types:
see list of patent claims
Composition; Compound; Device; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,925,829: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 10,925,829, focusing on its claims, scope, and the broader patent landscape.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and what is protected by the patent. The claims must be clear, concise, and specific to ensure that the invention is adequately described and distinguished from prior art[3].

Independent and Dependent Claims

Patent 10,925,829, like other patents, includes both independent and dependent claims. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit the independent claims.

Scope of the Patent

The scope of a patent is determined by its claims. A broader scope can provide more extensive protection but may also face more challenges during the examination process. Narrower claims, on the other hand, are more likely to be granted but offer less protection[3].

Metrics for Measuring Patent Scope

Researchers use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can indicate the breadth and complexity of the patent claims. For example, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent 10,925,829: Specifics

Overview

United States Patent 10,925,829 is related to pharmaceutical drugs, as indicated by the detailed information available on drug patent databases[5].

Claims Analysis

To analyze the claims of this patent, one would typically start by identifying the independent claims, which define the core of the invention. These claims should be examined for their specificity, breadth, and how they distinguish the invention from prior art.

Independent Claims

Independent claims in Patent 10,925,829 would outline the fundamental aspects of the pharmaceutical drug, such as its composition, method of manufacture, or method of use. These claims are critical as they set the boundaries of what is protected.

Dependent Claims

Dependent claims would further refine the independent claims, adding specific details or limitations. These claims help to narrow down the scope and ensure that the patent is not overly broad.

Scope and Protection

The scope of Patent 10,925,829 is defined by its claims and is intended to protect the specific pharmaceutical drug or method described. This protection includes the exclusive right to make, use, or sell the invention, as granted by the USPTO[4].

Patent Landscape

Global Context

The patent landscape for pharmaceutical drugs is complex and global. Patents in this field are often filed in multiple jurisdictions to ensure broad protection. Resources like the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) provide databases to search for similar patents globally[1].

International Patent Databases

Databases such as esp@cenet (EPO), PATENTSCOPE (WIPO), and KIPRIS (Korea) offer access to international patent collections. These resources are essential for conducting thorough patent searches to ensure that the invention is novel and nonobvious[1].

Patent Family and Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This tool is invaluable for understanding the global reach and status of a patent like 10,925,829[1].

Search Tools and Resources

USPTO Resources

The USPTO provides several tools for searching patents, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. The Public Search Facility in Alexandria, VA, and Patent and Trademark Resource Centers (PTRCs) also offer assistance in patent searching[1].

Common Citation Document (CCD)

The CCD application consolidates prior art citations from participating IP Offices, helping to visualize the search results for the same invention on a single page. This is particularly useful for understanding the prior art landscape relevant to Patent 10,925,829[1].

Statistical Trends in Pharmaceutical Patents

USPTO Patent Activity

In 2018, the USPTO awarded 309,000 utility patents, with a significant portion related to pharmaceuticals and biotechnology. This trend indicates the ongoing innovation and patent activity in the pharmaceutical sector[4].

Technology Areas

Patents in the pharmaceutical field are often classified under specific technology areas, such as chemistry and instruments. The increase in electrical engineering patents, including those related to information and communication technologies (ICT), also impacts the broader patent landscape[4].

Key Takeaways

  • Patent Claims: The claims of a patent define its scope and protection. Independent claims are crucial, while dependent claims further refine them.
  • Scope Analysis: Metrics like independent claim length and count help measure the scope. Narrower claims are more likely to be granted but offer less protection.
  • Global Patent Landscape: Pharmaceutical patents are filed globally, and resources like EPO, JPO, and WIPO databases are essential for thorough searches.
  • Search Tools: USPTO resources, including the Patent Public Search tool and Global Dossier, are vital for understanding the patent family and prior art.
  • Statistical Trends: The pharmaceutical sector sees significant patent activity, with trends indicating ongoing innovation.

FAQs

Q: How do I search for existing patents related to my invention?

A: You can use the USPTO's Patent Public Search tool, visit the Public Search Facility, or contact your local Patent and Trademark Resource Center for assistance[1].

Q: What is the importance of independent claims in a patent?

A: Independent claims define the core of the invention and set the boundaries of what is protected by the patent. They must be clear, concise, and specific[3].

Q: How can I determine the scope of a patent?

A: The scope of a patent is determined by its claims. Metrics such as independent claim length and count can help measure the breadth and complexity of the patent claims[3].

Q: What resources are available for searching international patents?

A: Resources include the European Patent Office's esp@cenet, Japan Patent Office's database, World Intellectual Property Organization's PATENTSCOPE, and other national patent databases[1].

Q: Why is the Global Dossier service important?

A: The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices, providing a comprehensive view of the global patent status[1].

Sources

  1. USPTO: Search for patents - USPTO
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov
  3. SSRN: Patent Claims and Patent Scope
  4. NSF: Invention: U.S. and Comparative Global Trends
  5. DrugPatentWatch: Pharmaceutical drugs covered by patent 10,925,829. Claims ...

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,925,829

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cycle TASCENSO ODT fingolimod lauryl sulfate TABLET, ORALLY DISINTEGRATING;ORAL 214962-001 Dec 23, 2021 RX Yes No 10,925,829 ⤷  Subscribe Y ⤷  Subscribe
Cycle TASCENSO ODT fingolimod lauryl sulfate TABLET, ORALLY DISINTEGRATING;ORAL 214962-002 Dec 9, 2022 RX Yes Yes 10,925,829 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,925,829

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016209466 ⤷  Subscribe
Canada 2974375 ⤷  Subscribe
China 107530301 ⤷  Subscribe
European Patent Office 3247341 ⤷  Subscribe
Japan 2018502168 ⤷  Subscribe
Taiwan 201642842 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.